Esperion Therapeutics, Inc.ESPRNASDAQ
LOADING
|||
ROE: Returns Declining
Trending lower, above historical average.
Left:
||||
Return on equity
Latest
13.31%
↑ 186% above average
Average (9y)
-15.42%
Historical baseline
Range
High:149.32%
Low:-487.04%
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 13.31% | -71.1% |
| 2023 | 45.99% | -36.3% |
| 2022 | 72.17% | -47.2% |
| 2021 | 136.64% | -8.5% |
| 2020 | 149.32% | +130.7% |
| 2019 | -487.04% | -1543.4% |
| 2018 | 33.74% | +149.4% |
| 2017 | -68.24% | -108.1% |
| 2016 | -32.80% | -89.3% |
| 2015 | -17.33% | - |